SEC 13F Intelligence

Altium Capital Management LLC / CYTK

Altium Capital Management LLC’s Cytokinetics Inc Position

Does Altium Capital Management LLC own Cytokinetics Inc (CYTK)? Not currently — the last reported position was 20.0K shares worth $2M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2023
Shares
20.0K
% of Portfolio
+1.13%
Quarters Held
3
position exited

Position History CYTK

Reported value by quarter
Q1 ’21: $2MQ1 ’21Q2 ’21: $2MQ2 ’21Q4 ’23: $2MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202320.0K$2M+1.13%
Q2 202184.3K$2M+0.39%
Q1 2021103.3K$2M+0.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of CYTK.